HHS asks for input on paying clinical trial participants without breaking anti-kickback laws
/ 1 min read
Table of Contents
The Department of Health and Human Services is asking the public how it should handle payments to people who join medical research studies. Currently, it is unclear whether certain benefits like travel money, childcare help, or stipends violate federal fraud and abuse laws. HHS wants to know if these payments actually encourage more diverse groups to join trials and stay in them.
Why it matters: This matters because medical research relies on volunteers who reflect the general population. If participants face financial barriers like transportation or childcare costs, they may drop out or never join in the first place. Clear rules could speed up drug development and improve the quality of data by ensuring trials include a broader range of people. For now, this is just a request for information, not a new rule.
Who it affects
- Clinical trial sponsors, including pharmaceutical companies and research organizations
This is a proposed request for information from the Department of Health and Human Services published in the Federal Register; readers should check the original document for full details before relying on it.
Agency: Health and Human Services Department,
Source: Federal Register — read the official document